Pseudohypoglycemia

Back

Overview

Pseudohypoglycemia is an event when a person experiences typical symptoms of hypoglycemia but with a measured plasma glucose concentration above 70 mg/dL (>3.9 mmol/L).[1, 2] The term was used in the past to describe disparity in actual and measured plasma/ capillary glucose.

The term clinical pseudohypoglycemia is used when patients with personality and psychological disorders report relief of symptoms (eg, mental dullness, disorientation, confusion, palpitations) after eating. Plasma glucose levels are within reference ranges in all such patients while they are symptomatic.[3, 4]

It is important for clinicians to recognize the difference between true and pseudohypoglycemia to prevent unnecessary investigations or treatment for the same.

Causes

Pseudohypoglycemia or artifactual hypoglycemia can occur in the following situations:

                   Severe acidosis (pH <6.95) can falsely decrease glucose readings[22]

                   Patients receiving high flow oxygen can have false low readings with glucose meter using glucose oxidase method[22]

                   High hematocrit as in neonates can also cause false low blood glucose readings.[25]

 

Laboratory Studies

Venous plasma glucose concentration greater than 70 mg/dL (3.9 mmol/L) after an overnight fast are within reference ranges. As per ADA guidelines, hypoglycemia is considered if plasma glucose is less than 70 mg/dL (3.9 mmol/L).[26] However, in some groups of patients, like young females, values of 50-70 mg/dL (2.8-3.9 mmol/L) may be normal.[27]

Plasma insulin levels and levels of compensatory counterregulatory hormones, such as glucagon, cortisol, growth hormone, and catecholamines, are within reference ranges when pseudohypoglycemia is found.

Evaluating concurrent blood count as well as other parameters like protein is important to evaluate the cause for falsely low glucose levels.

Historical Perspective

Since the discovery of insulin in 1924, hypoglycemic symptoms have been reported in nondiabetic patients. It was thought to result from dysinsulinism.[28] In 1975, Yager and Young described a syndrome of nonhypoglycemia in which patients presented with varied spectrum of symptoms that they attributed to low glucose.[29]

In 1961, Field et al used the term artifactual hypoglycemia to describe the falsely low glucose that occurred in patients with chronic myelogenous leukemia.[30]

The terms pseudohypoglycemia and artifactual hypoglycemia have been used since then to describe the symptomatology.

Clinical Symptoms

The patients may be asymptomatic and they may be subjected to unnecessary testing based on the abnormal laboratory result. Occasionally, patients may present with nonspecific symptoms such as fatigue, headache, visual disturbances, and lightheadedness.

Clinical correlation becomes of utmost importance in such circumstances. Some patients may present with typical symptoms of neuroglycopenia like slurred speech, confusion, and, rarely, seizures and coma, in which case further workup is required.

The clinical diagnosis of hypoglycemia is established when symptoms are consistent with hypoglycemia, a low plasma glucose concentration is confirmed, and symptoms subside in the presence of normal plasma glucose levels (Whipple's triad).

Evaluation

Absence of symptoms with low glucose values should raise the suspicion of artifactual hypoglycemia. The following actions are recommended in an effort to prevent it:

Author

Catherine Anastasopoulou, MD, PhD, FACE, Associate Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University; Attending Endocrinologist, Department of Medicine, Albert Einstein Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Goral Panchal, MD, Fellow in Endocrinology, Albert Einstein Medical Center

Disclosure: Nothing to disclose.

Janna Prater, MD, Fellow in Endocrinology, Albert Einstein Medical Center

Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD, Professor Emeritus of Medicine, St Louis University School of Medicine

Disclosure: Nothing to disclose.

References

  1. Seaquist ER, Anderson J, Childs B,et al. Hypoglycemia and Diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes care. May 2013. 36(5):1384-1395. [View Abstract]
  2. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab. 2013 May. 98(5):1845-59. [View Abstract]
  3. Elks ML. Pseudohypoglycemia in adult victims of adolescent incest. South Med J. 1990 Nov. 83(11):1338-40. [View Abstract]
  4. Petrella V, Silvera F, Massara G. [Syndrome of clinical pseudohypoglycemia]. Minerva Med. 1984 Nov 30. 75(45-46):2751-4. [View Abstract]
  5. El Khoury M, Yousuf F, Martin V, et al. Pseudohypoglycemia: a cause for unreliable finger-stick glucose measurements. Endocr Pract. 2008 Apr. 14(3):337-9. [View Abstract]
  6. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol. 1976 Oct. 41(4):565-73. [View Abstract]
  7. Tarasova VD, Zana M, Rendell M. Artifactual hypoglycemia: an old term for a new classification. Diabetes care. 2014. 37:e85-e86.
  8. Crevel E, Ardigo S, Perrenoud L et al. Acrocyanosis as a cause of pseudo hypoglycemia. J Am Geriatric Soc. August 2009. 57(8):1517-20. [View Abstract]
  9. Theofilogiannakos EK, Giannakoulas G, Ziakas A, Karvounis HI, Styliadis IH. Pseudohypoglycemia in a patient with the Eisenmenger syndrome. Ann Intern Med. 2010 Mar 16. 152(6):407-8. [View Abstract]
  10. Astles JR, Petros WP, Peters WP, Sedor FA. Artifactual hypoglycemia associated with hematopoietic cytokines. Arch Pathol Lab Med. 1995 Aug. 119(8):713-6. [View Abstract]
  11. Ybarra J, Isern J. Leukocytosis-induced artifactual hypoglycemia. Endocr J. 2003 Aug. 50(4):481-2. [View Abstract]
  12. Assaad SN, Vassilopoulou-Sellin R, Samaan NA. Pseudohypoglycemia in chronic leukemia. Tex Med. 1988 Jul. 84(7):36-7. [View Abstract]
  13. Canivet B, Elbaze P, Dujardin P. Pseudohypoglycemia in a patient with leukemia [letter]. Biomedicine. 1981 Dec. 35(7-8):203-4. [View Abstract]
  14. Rawnsley HM, Bowman HM. Autoglycolysis in leukemic and non-leukemic blood. Am J Med Sci. 1965 Feb. 249:203-10. [View Abstract]
  15. Arem R, Jeang MK, Blevens TC, Waddell CC, Field JB. Polycythemia rubra vera and artifactual hypoglycemia. Arch Intern Med. 1982 Nov. 142(12):2199-201. [View Abstract]
  16. Farfel Z, Freimark D, Mayan H, Gafni J. Spurious hypoglycemia, hyperkalemia and hypoxemia in chronic hemolytic anemia. Isr J Med Sci. 1990 Nov. 26(11):606-10. [View Abstract]
  17. Jokinen CH, Swaim WR, Nuttall FQ. A case of hereditary xerocytosis diagnosed as a result of suspected hypoglycemia and observed low glycohemoglobin. J Lab Clin Med. 2004 Jul. 144(1):27-30. [View Abstract]
  18. Nieman RE, Kelly JJ, Waskin HA. Severe African trypanosomiasis with spurious hypoglycemia. J Infect Dis. 1989 Feb. 159(2):360-2. [View Abstract]
  19. Haibach H, Wright DL, Bailey LE. Pseudohypoglycemia in a patient with Waldenstrom's macroglobulinemia, an artifact of hyperviscosity [letter]. Clin Chem. 1986 Jun. 32(6):1239-40. [View Abstract]
  20. Gertz MA. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012 May. 87(5):503-10. [View Abstract]
  21. Wenk RE, Yoho S, Bengzon A. Pseudohypoglycemia with monoclonal immunoglobulin m. Arch Pathol Lab Med. 2005 Apr. 129(4):454-5. [View Abstract]
  22. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009 Jul 1. 3 (4):971-80. [View Abstract]
  23. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000 Jan. 113(1):75-86. [View Abstract]
  24. Kimura T, Kozawa J, Matsui M, Nishizawa H, Yasuda T, Otsuki M. Pseudohypoglycemia or hyperglycemia caused by interference with self-monitoring blood glucose measurements in anticancer ascorbic acid therapy. J Diabetes Investig. 2013 Nov 27. 4(6):679-80. [View Abstract]
  25. Balion C, Grey V, Ismaila A, Blatz S, Seidlitz W. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr. 2006 Nov 3. 6:28. [View Abstract]
  26. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005 May. 28(5):1245-9. [View Abstract]
  27. Gregory JW, Aynsley-Green A. The definition of hypoglycaemia. Baillieres Clin Endocrinol Metab. 1993 Jul. 7(3):587-90. [View Abstract]
  28. Harris S. Hyperinsulinism and dysinsulinism. JAMA. 1924. 83:729-733.
  29. Yager J, Young RT. Non-hypoglycemia is an epidemic condition. N Engl J Med. 1974 Oct 24. 291(17):907-8. [View Abstract]
  30. Fields JB, Williams HE. Artifactual hypoglycemia associated with leukemia. N Engl J Med. 1961. 265:946-948.